The TRUST Study - CardioVascular Imaging IMT
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 184 participants.
Also called NCT02832934
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 184 participants
- Sponsor
- Registry
-
NCT02832934
-
- Other papers using this trial's data
- Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT02832934. Randomized; quadruple masking; primary purpose treatment. Start 2016-06 (registry gives no type); primary completion 2016-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The TRUST Study - CardioVascular Imaging IMT
- Condition
- Thyroid Dysfunction
- Condition
- Atherosclerosis
- Condition
- Heart Failure
- Intervention (Drug)
- Levothyroxine
- Intervention (Drug)
- Placebo
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Collaborator
- University of Lausanne Hospitals
- Collaborator
- University Hospital, Geneva
Record details
- Record id
cardio:ct-nct02832934- Content hash
b53388caa13ed46d1ea598169aaa59b285058f7023cb9d8d711be72925a3266e